---
type: "Symbol"
title: "Grande (GRAN.US) — Community Discussions"
description: "Community discussions about this stock, including analyst opinions, earnings analysis, and investment strategies from verified financial professionals and active investors."
locale: "en"
url: "https://longbridge.com/en/quote/GRAN.US/topics.md"
symbol: "GRAN.US"
parent: "https://longbridge.com/en/quote/GRAN.US.md"
count: 2
datetime: "2026-03-10T03:49:34.300Z"
locales:
  - [en](https://longbridge.com/en/quote/GRAN.US/topics.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/GRAN.US/topics.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/GRAN.US/topics.md)
---

# Grande (GRAN.US) — Community Discussions

### [Weijian Pharmaceuticals IPO: From a huge loss of 92.8 million yuan to a profit of 24.04 million yuan, how long can the "bottom-fishing" dividend last?](https://longbridge.com/en/topics/36195252.md)

- Author: [医药研究社](https://longbridge.com/en/profiles/15545088.md)
- Datetime: 2025-11-10T12:55:33.000Z
- Comments: 0
- Against the backdrop of the rise of domestic innovative drugs, some multinational pharmaceutical companies have begun to reposition the Chinese market and opted for strategic exits. For example, in Au

### [$Grande(GRAN.US)](https://longbridge.com/en/topics/35690186.md)

- Author: [JacobZhang](https://longbridge.com/en/profiles/23976771.md)
- Datetime: 2025-10-28T14:14:14.000Z
- Comments: 0
- $Grande(GRAN.US)

## References

- [Grande (GRAN.US)](https://longbridge.com/en/quote/GRAN.US.md)


> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/GRAN.US/topics.md) | [繁體中文](https://longbridge.com/zh-HK/quote/GRAN.US/topics.md)